Mushrooms Inc. (MSRM)
| Previous close | 0.0279 |
| Open | 0.0279 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.0279 - 0.0279 |
| 52-week range | 0.0150 - 0.1500 |
| Volume | |
| Avg. volume | 52,426 |
| Market cap | 2.279M |
| Beta (5Y monthly) | -0.00 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0000 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireMushrooms Inc. (OTC:MSRM) Launches New Health Supplements, Progresses with German Partnership, and Boosts Engagement Initiatives
ESTERO, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- via IBN -- Mushrooms Inc., (OTC: MSRM) a developing leader in biotechnology and sustainable healthcare innovation using mushrooms and mycelium, is excited to announce a suite of strategic initiatives aimed at transforming the healthcare landscape. These initiatives include the launch of two groundbreaking health supplements, LONGEVITY and SPORT+, and the exploration of a development collaboration with a renowned scientific team in Germany. These e
- GlobeNewswire
Mushrooms Inc (OTC:MSRM) Announces Full Patent Filing for Groundbreaking Mycelium Technology Providing Bacterial Detection and Nutrient Delivery
ESTERO, Fla., Oct. 18, 2023 (GLOBE NEWSWIRE) -- via IBN -- Mushrooms Inc., (OTC: MSRM) a leader in mycelium research and development, proudly announces the successful filing of its non-provisional patent, titled "METHOD OF GENERATING MULTIFUNCTIONAL MYCELIUM PRODUCTS". This revolutionary patent showcases a unique approach to bacterial detection and nutrient delivery, marking a significant shift from the company's previous provisional filing. Kimberly Carlson, CEO of MSRM, remarked, "With the Pha
